PRODUCTS

FJlebtOPnbuzcbi

FJlebtOPnbuzcbi (6413)

16220

I'd like to change some money remeron sleeping tablets The issue here is one of risk. Investors are currently paying 21 times forecast 2013 earnings. That looks expensive when compared with peer Aggreko that trades on 17 times 2013 forecast earnings. Aggreko may be facing a slowdown in growth, hence the recent sell-off but it has much more reliable earnings.

I'd like to change some money remeron sleeping tablets The issue here is one of risk. Investors are currently paying 21 times forecast 2013 earnings. That looks expensive when compared with peer Aggreko that trades on 17 times 2013 forecast earnings. Aggreko may be facing a slowdown in growth, hence the recent sell-off but it has much more reliable earnings.

VAT Relief available

£6.00 Excluding VAT

£7.20 Including VAT

Website maintained by CIUK